University of Cincinnati

The university will use the technology to screen blood samples for certain clinically actionable mutations in non-small cell lung cancer patients.

Researchers sequenced mothers who experienced preterm birth and found a possible role for steroid signaling in birth timing.

This Week in PNAS

In PNAS this week: genome and transcriptome sequencing study of tobacco plants, molecular effects of cytochrome c oxidase mutations, and more.

In blood samples from infected individuals, a seven-gene signature apparently distinguishes between bacterial and viral culprits, a distinction important to antibiotic use.

Recently established biomedical informatics divisions at the hospital support projects like Bench-to-Bassinet and the Longitudinal Pediatric Data Resource.

Scientists will look for genetic causes of craniofacial asymmetries and loss of skin pigmentation in a cave-dwelling fish that could shed light on similar conditions in humans.

The goal is to identify patient-specific rearrangements in the primary tumor, and then check for the presence of that rearrangement in the patient's blood during treatment in order to determine tumor progression and monitor therapy response.

In the deal with the University of Cincinnati, Drug Discovery Center, Proteros will provide biotechnology and drug firms access to UC DCC's ultra-high throughput and high-content screening platform along with a library of more than 340,000 drug-like compounds.

The technique is based on a MALDI triple-quadrupole platform and exploits the selective multiple-reaction monitoring transition features of the instrument to circumvent problems resulting from interference that can plague existing methods.

The change is expected to help the state translate the approximately $1.5 billion in research generated annually at Ohio's public higher education institutions into goods and services and create jobs by "substantially increasing" the number of university startups in the state, an official said.

Pages

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.